An obesity drug could cut heart disease and stroke risks even if you don’t lose any weight. New research has shown that ...
Semaglutide, also known as Ozempic or Wegovy, is set to transform treatments for cardiovascular disease, but a change in ...
Anti-obesity jabs could reduce the risk of heart attacks, strokes or heart failure in obese people regardless of the amount ...
Jabs designed to combat obesity might lower the likelihood of heart attacks, strokes, or heart failure among obese ...
Injections of a weight loss drug could be a ‘game changer’ for cardiovascular patients by cutting the risk of heart attacks or strokes.
The popular drug Wegovy also is found to reduce the risk of strokes and heart attacks in patients no matter how much they weighed, a new study concludes.